Boundless Bio, Inc.
BOLD • NASDAQ
Boundless Bio, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Zachary Hornby, with a market cap of $24.9M.
CEOZachary Hornby
Next Earnings
Upcoming earnings announcement for Boundless Bio, Inc.
Date
Friday, May 8, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.54
Earnings History
Past 12 earnings reports for Boundless Bio, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | Q4 2025 | -$0.58Est: -$0.49 | -18.4% | - | — |  10-K |
| Nov 5, 2025 | Q3 2025 | -$0.62Est: -$0.56 | -10.7% | - | — | 10-Q |
| Aug 5, 2025 | Q2 2025 | -$0.70Est: -$0.69 | -1.4% | - | — | 10-Q |
| May 9, 2025 | Q1 2025 | -$0.71Est: -$0.75 | +5.3% | - | — | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.74Est: -$0.78 | +5.1% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.74Est: -$0.75 | +1.3% | - | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.77Est: -$0.80 | +3.8% | - | — | 10-Q |
| May 13, 2024 | Q1 2024 | -$12.27 | — | - | — | 10-Q |
| Nov 7, 2019 | Q3 2019 | -$1.00Est: -$1.07 | +6.5% | - | — | — |
| Aug 6, 2019 | Q2 2019 | -$1.01Est: -$1.03 | +1.9% | - | — | — |
| May 7, 2019 | Q1 2019 | -$1.13Est: -$0.89 | -27.0% | - | — | — |
| Feb 27, 2019 | Q4 2018 | -$0.84Est: -$0.92 | +8.7% | - | — | — |